Gambia Reports First Confirmed Mpox Case Amid Regional Rise
The Gambia has confirmed its first mpox case, adding to regional concerns as neighboring countries face rising infection rates. Public health measures are underway to contain the outbreak.
On July 23, 2025, The Gambia announced the detection of its first mpox case, signaling the start of an outbreak in the country. The case was identified through routine surveillance, with the patient confirmed on the preceding Friday. This development comes at a time when several neighboring nations in West Africa are experiencing a surge in mpox infections.
Mpox, caused by a virus related to smallpox, is a zoonotic disease that can be transmitted to humans from infected animals, but human-to-human transmission through close contact is also common. The symptoms include fever, muscle aches, and large skin lesions similar to boils, which can sometimes lead to severe health outcomes.
The World Health Organization has classified mpox as an ongoing international health emergency due to its recent increase in cases across West Africa. In response to the new case, the Gambia's Ministry of Health has launched contact tracing, enhanced community engagement, and other measures to prevent further spread.
Authorities are currently conducting genetic sequencing to determine the specific subtype of the virus involved in the outbreak. Historically, neighboring countries such as Sierra Leone, Liberia, and Guinea have reported hundreds to thousands of cases this year, with Sierra Leone reporting over 3,300 cases and Guinea exceeding 200 since September last year. Cases have also been documented in DRC, Uganda, and Burundi.
This development highlights the importance of vigilant monitoring and swift public health responses to control mpox outbreaks in the region.
Source: https://medicalxpress.com/news/2025-07-gambia-declares-mpox-outbreak.html
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
Questioning the Reliability of FDA-Approved Metrics for Rectal Cancer Drug Effectiveness
A new study questions the reliability of the FDA-supported metric, pathologic complete response, used to evaluate the effectiveness of rectal cancer treatments, suggesting it may not predict long-term survival.
Saliva Testing Equates to Blood Tests for Managing Epilepsy with Keto Diet
A groundbreaking saliva test now matches blood tests in accurately monitoring ketone levels for epilepsy management, offering a painless alternative for children and adults on the ketogenic diet.
Single Brain Scan Could Predict Risk of Age-Related Conditions Like Dementia
A new MRI-based biomarker, DunedinPACNI, developed by researchers, can predict individual aging rates from a single brain scan at midlife, enabling early intervention for age-related diseases like dementia.
Elevating Potassium Levels May Reduce Risks in High-Risk Cardiac Patients
New research suggests that maintaining higher-normal potassium levels can significantly lower the risk of ventricular arrhythmias and improve outcomes in high-risk cardiac patients, offering a simple and cost-effective treatment approach.